Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral contraception: trends over time.

A Albert Yuzpe1

  • 1Genesis Fertility Centre, 550-555 West Twelfth Avenue, Vancouver, British Columbia V5Z 3X7, Canada.

The Journal of Reproductive Medicine
|December 25, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Brief Overview of the History of In Vitro Fertilization in Canada.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2019
Same author

Bref survol de l'histoire de la fécondation in vitro au Canada.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2019
Same author

Estimating the prevalence of infertility in Canada.

Human reproduction (Oxford, England)·2012
Same journal

Elective Procedures in Obstetrics and Gynecology During the COVID-19 Pandemic.

The Journal of reproductive medicine·2022
Same journal

Choriocarcinoma in Situ in a Partial Hydatidiform Mole A: Case Report.

The Journal of reproductive medicine·2018
Same journal

Isolated Recurrent Hematotrachelos After Abdominal Myomectomy A Case Report.

The Journal of reproductive medicine·2018
Same journal

Live Birth from Electively Cryopreserved Oocytes: A Feasible Option for Couples Opposed to Embryo Cryopreservation A Case Report.

The Journal of reproductive medicine·2018
Same journal

Prevalence and Risk Factors of Ejaculation Failure on the Day of Operation Among Chinese Males Undergoing Assisted Reproductive Technique Treatments.

The Journal of reproductive medicine·2018
Same journal

Efficacy and Safety of Perioperative Use of Epinephrine for Laparoscopic Myomectomy in Infertile Women with Symptomatic Solitary Intramural Uterine Fibroids A Randomized Clinical Trial.

The Journal of reproductive medicine·2018
See all related articles

Oral contraceptives have evolved with lower doses and new progestins like drospirenone. Effective counseling is key to improving compliance and managing side effects for women using these beneficial birth control methods.

Area of Science:

  • Reproductive Health
  • Pharmacology
  • Women's Health

Background:

  • Oral contraceptives (OCs) introduced in 1960 have significantly evolved in formulation and dosage.
  • Modern OCs primarily use ethinyl estradiol and 19-nortestosterone derivatives, with drospirenone representing a novel progestin derived from spironolactone.
  • Despite low failure rates with ideal use, actual usage compliance is a challenge due to early discontinuation from side effects.

Purpose of the Study:

  • To review the evolution of oral contraceptive formulations and their impact on efficacy and side effect profiles.
  • To highlight the benefits of oral contraceptives beyond contraception, including managing menstrual irregularities and premenstrual symptoms.
  • To emphasize the importance of patient education and counseling for improving compliance and addressing health risk perceptions.

Related Experiment Videos

Main Methods:

  • Review of historical data and current literature on oral contraceptive development and usage.
  • Analysis of hormonal components, dosages, and non-contraceptive applications of combination oral contraceptives.
  • Examination of factors influencing patient compliance and strategies for effective patient counseling.

Main Results:

  • Combination oral contraceptives have seen dramatic decreases in steroid component dosages since their inception.
  • Drospirenone, a novel progestin, is available in newer formulations combined with ethinyl estradiol.
  • While risks exist, the overall health benefits of oral contraceptives, including non-contraceptive uses, are considered to outweigh potential risks.

Conclusions:

  • Oral contraceptives offer significant benefits for women's health, including effective contraception and management of gynecological conditions.
  • Improving patient education and counseling is crucial for enhancing compliance and mitigating side effect concerns.
  • Accurate information regarding health risks and benefits empowers women to make informed decisions about oral contraceptive use.